SCHEMBL29375458

SCHEMBL29375458

N#Cc1ccc2cc(Cl)ccc2c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 2/20 0.50
MAOA P21397 1/20 0.47
MAOB P27338 1/20 0.47
CA1 P00915 2/20 0.46
CA2 P00918 2/20 0.46
GPR35 Q9HC97 1/20 0.44
IMPDH2 P12268 1/20 0.44
IMPDH1 P20839 1/20 0.44
CYP11B1 P15538 2/20 0.43
CYP11B2 P19099 2/20 0.43
CYP17A1 P05093 1/20 0.43
SLC6A4 P31645 2/20 0.41
SLC6A3 Q01959 2/20 0.41
KCNH2 Q12809 1/20 0.41
LMNA P02545 1/20 0.40
MAPT P10636 1/20 0.40
TSHR P16473 1/20 0.40
HTT P42858 1/20 0.40
NLRP3 Q96P20 1/20 0.40
F2 P00734 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22137620 1.00 CYP2A6 (0.50) CYP2A6MAOAMAOBCA1CA2
SCHEMBL1344485 0.85 CYP2A6 (0.54) CYP2A6CA1CA2IMPDH2IMPDH1
SCHEMBL29489119 0.85 CYP2A6 (0.54) CYP2A6CA1CA2IMPDH2IMPDH1
SCHEMBL22155066 0.84 CYP11B1 (0.54) MAOAMAOBCA1CA2CYP11B1
SCHEMBL22127131 0.84 HRH3 (0.50) CYP2A6MAOAMAOBCYP11B1CYP11B2
SCHEMBL13074509 0.80 CYP2A6 (0.50) CYP2A6CA1CA2IMPDH2IMPDH1
SCHEMBL29489123 0.78 CYP2A6 (0.52) CYP2A6CA1CA2IMPDH2IMPDH1
SCHEMBL1341822 0.78 CYP2A6 (0.52) CYP2A6CA1CA2IMPDH2IMPDH1
SCHEMBL9633299 0.77 GPR35 (0.53) CYP2A6MAOAMAOBCA1CA2
SCHEMBL2347410 0.77 CYP2A6 (0.50) CYP2A6MAOBGPR35LMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3708568-B1 COMPOUND CAPABLE OF INHIBITING PHOSPHODIESTERASE 4, PREPARATION METHOD, AND MEDICAL USE THEREOF HEFEI INDUSTRIAL PHARMACEUTICAL INST CO LTD (CN) 2022-02-09 EP disclosed